[1]
LĂȘ, T.T.X. et al. 2024. THE PREVALENCE OF ADVERSE EVENTS FOLLOWING IMMUNIZATION OF THE 2ND DOSE OF VERO CELL (SINOPHARM) COVID-19 VACCINE AMONG PEOPLE VACCINATED AT THE VACCINATION SITE OF HANOI MEDICAL UNIVERSITY AND SOME RELATED FACTORS, 2021-2022. Vietnam Medical Journal. 540, 2 (Jul. 2024). DOI:https://doi.org/10.51298/vmj.v540i2.10389.